C10BA05 • ezetimibe + atorvastatin • Cardiovascular system | Lipid modifying agents, combinations | Combinations of various lipid modifying agents
The combination of ezetimibe and atorvastatin is used to lower total cholesterol and LDL ('bad') cholesterol levels in the blood. Ezetimibe reduces cholesterol absorption in the intestines, while atorvastatin decreases cholesterol production in the liver. Together, these medications help prevent cardiovascular diseases such as heart attack or stroke.
The medication is taken orally as prescribed by the doctor, usually once a day. The dose is adjusted based on blood test results and the patient's cardiovascular risk. It is important for the patient to follow a low-fat diet and maintain a healthy lifestyle during treatment.
Side effects may include muscle pain, increased liver enzyme levels, digestive disorders, or, rarely, severe allergic reactions. In rare cases, serious muscle conditions such as rhabdomyolysis may occur. Any unusual symptoms should be reported to the doctor immediately.
The combination of ezetimibe and atorvastatin is effective in controlling cholesterol levels, but requires regular medical monitoring. Following the doctor's recommendations and being informed about possible side effects are essential for safe and effective treatment.
Substance: ezetimibe + atorvastatin
Date of last drug list: 01-05-2026
Commercial code: W66281001
Concentration: 10mg / 20mg
Pharmaceutical form: capsules
Quantity: 30
Product type: original
Price: 89.54 RON
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Manufacturer: EGIS PHARMACEUTICALS PLC - UNGARIA
Holder: EGIS PHARMACEUTICALS PLC - UNGARIA
Number: 15534/2024/01
Shelf life: 30 months
Price
Copayment
Patient
89.54 RON
13.47 RON
76.07 RON